Who Paid My Doc
Wilate - Von Willebrand Factor/Coagulation Factor VIII Complex (Human)
Biological Coagulation
NDC 68982-182-01
General payments
$1,194,684
Research payments
$2,583,268
Through program year 2025, $1,194,684 in general payments and $2,583,268 in research payments were reported against Wilate - Von Willebrand Factor/Coagulation Factor VIII Complex (Human) (Coagulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
13 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $780,905 | 134 |
| 2024 | General | $195,286 | 124 |
| 2024 | Research | $40,501 | 4 |
| 2023 | General | $69,315 | 142 |
| 2023 | Research | $2,004,572 | 7 |
| 2022 | General | $88,783 | 209 |
| 2022 | Research | $5,785 | 3 |
| 2021 | General | $31,504 | 80 |
| 2021 | Research | $376,867 | 18 |
| 2020 | General | $5,725 | 39 |
| 2020 | Research | $141,943 | 12 |
| 2019 | General | $23,167 | 255 |
| 2019 | Research | $13,600 | 2 |
Breakdown
The top 5 of 41 recipients; each share is of general payments naming this product in 2025.
The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 17 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
983 general · 46 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.